| 0.9 |
2.6 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.5 |
2.2 |
GO:1901675 |
negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.5 |
1.5 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.5 |
1.5 |
GO:0098974 |
postsynaptic actin cytoskeleton organization(GO:0098974) |
| 0.5 |
1.5 |
GO:0072076 |
nephrogenic mesenchyme development(GO:0072076) |
| 0.5 |
2.9 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.5 |
0.5 |
GO:0071442 |
regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.4 |
1.3 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.4 |
2.2 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.4 |
4.3 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.4 |
1.7 |
GO:0010609 |
mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.4 |
2.1 |
GO:0007066 |
female meiosis sister chromatid cohesion(GO:0007066) |
| 0.4 |
1.2 |
GO:0014737 |
positive regulation of muscle atrophy(GO:0014737) |
| 0.4 |
1.2 |
GO:0098749 |
cerebellar neuron development(GO:0098749) |
| 0.4 |
1.9 |
GO:1904995 |
negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.4 |
1.5 |
GO:1904800 |
regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
| 0.4 |
0.4 |
GO:0014735 |
regulation of muscle atrophy(GO:0014735) |
| 0.3 |
1.0 |
GO:2000386 |
negative regulation of integrin activation(GO:0033624) positive regulation of ovarian follicle development(GO:2000386) regulation of antral ovarian follicle growth(GO:2000387) positive regulation of antral ovarian follicle growth(GO:2000388) negative regulation of eosinophil migration(GO:2000417) |
| 0.3 |
1.3 |
GO:0045358 |
negative regulation of interferon-beta biosynthetic process(GO:0045358) |
| 0.3 |
0.6 |
GO:2000793 |
cell proliferation involved in heart valve development(GO:2000793) |
| 0.3 |
1.5 |
GO:1904048 |
regulation of spontaneous neurotransmitter secretion(GO:1904048) |
| 0.3 |
1.2 |
GO:0003017 |
lymph circulation(GO:0003017) |
| 0.3 |
1.8 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.3 |
1.2 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.3 |
2.3 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.3 |
2.8 |
GO:0046959 |
habituation(GO:0046959) |
| 0.3 |
1.4 |
GO:1901297 |
positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
| 0.3 |
5.0 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.3 |
0.8 |
GO:0040040 |
thermosensory behavior(GO:0040040) |
| 0.3 |
2.7 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.3 |
1.3 |
GO:1903181 |
regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 0.3 |
0.5 |
GO:0060061 |
Spemann organizer formation(GO:0060061) |
| 0.3 |
1.0 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.3 |
2.0 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.2 |
1.2 |
GO:0044727 |
DNA demethylation of male pronucleus(GO:0044727) |
| 0.2 |
0.9 |
GO:1905051 |
regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.2 |
0.9 |
GO:0061534 |
gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 0.2 |
0.7 |
GO:0035441 |
cell migration involved in vasculogenesis(GO:0035441) |
| 0.2 |
0.7 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.2 |
3.5 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.2 |
0.9 |
GO:1904428 |
negative regulation of tubulin deacetylation(GO:1904428) |
| 0.2 |
1.8 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.2 |
1.4 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.2 |
1.1 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) |
| 0.2 |
0.9 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.2 |
0.8 |
GO:0098582 |
innate vocalization behavior(GO:0098582) |
| 0.2 |
1.5 |
GO:0007527 |
adult somatic muscle development(GO:0007527) |
| 0.2 |
2.1 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.2 |
1.4 |
GO:1902748 |
positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.2 |
1.0 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 0.2 |
0.6 |
GO:1990926 |
short-term synaptic potentiation(GO:1990926) |
| 0.2 |
0.2 |
GO:2001223 |
negative regulation of neuron migration(GO:2001223) |
| 0.2 |
0.6 |
GO:0002017 |
regulation of blood volume by renal aldosterone(GO:0002017) |
| 0.2 |
0.9 |
GO:0000973 |
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.2 |
0.9 |
GO:1904953 |
Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
| 0.2 |
1.8 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.2 |
0.7 |
GO:0034552 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.2 |
0.5 |
GO:1900195 |
positive regulation of oocyte maturation(GO:1900195) |
| 0.2 |
0.9 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.2 |
0.7 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.2 |
0.5 |
GO:2001200 |
positive regulation of dendritic cell differentiation(GO:2001200) |
| 0.2 |
0.3 |
GO:0061184 |
positive regulation of dermatome development(GO:0061184) |
| 0.2 |
0.5 |
GO:1904582 |
positive regulation of intracellular mRNA localization(GO:1904582) |
| 0.2 |
0.5 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.2 |
0.7 |
GO:2000657 |
regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 0.2 |
0.5 |
GO:0003241 |
growth involved in heart morphogenesis(GO:0003241) |
| 0.2 |
0.3 |
GO:1901189 |
regulation of cell adhesion involved in heart morphogenesis(GO:0061344) positive regulation of ephrin receptor signaling pathway(GO:1901189) |
| 0.2 |
0.5 |
GO:0034970 |
histone H3-R2 methylation(GO:0034970) |
| 0.2 |
1.3 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.2 |
0.6 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.2 |
0.6 |
GO:0070100 |
negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.2 |
0.5 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.2 |
2.0 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.2 |
0.2 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.2 |
0.5 |
GO:0002380 |
immunoglobulin secretion involved in immune response(GO:0002380) |
| 0.1 |
0.4 |
GO:1905072 |
cardiac jelly development(GO:1905072) |
| 0.1 |
0.4 |
GO:1903699 |
tarsal gland development(GO:1903699) |
| 0.1 |
0.9 |
GO:0032954 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.1 |
0.6 |
GO:0097274 |
urea homeostasis(GO:0097274) |
| 0.1 |
0.6 |
GO:0032765 |
positive regulation of mast cell cytokine production(GO:0032765) |
| 0.1 |
0.1 |
GO:0060266 |
regulation of respiratory burst involved in inflammatory response(GO:0060264) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
| 0.1 |
0.3 |
GO:0070671 |
response to interleukin-12(GO:0070671) |
| 0.1 |
1.0 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 0.1 |
0.7 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.1 |
1.0 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.1 |
1.4 |
GO:0002913 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.1 |
1.0 |
GO:0002447 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
| 0.1 |
1.5 |
GO:1901409 |
positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.1 |
0.7 |
GO:0031161 |
phosphatidylinositol catabolic process(GO:0031161) |
| 0.1 |
0.4 |
GO:0015881 |
creatine transport(GO:0015881) |
| 0.1 |
0.8 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
| 0.1 |
0.5 |
GO:0055048 |
regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 0.1 |
0.4 |
GO:0003358 |
noradrenergic neuron development(GO:0003358) |
| 0.1 |
0.4 |
GO:0044340 |
canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.1 |
0.4 |
GO:0098884 |
postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 0.1 |
0.9 |
GO:0051295 |
establishment of meiotic spindle localization(GO:0051295) |
| 0.1 |
0.4 |
GO:0060466 |
activation of meiosis involved in egg activation(GO:0060466) |
| 0.1 |
0.1 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.1 |
0.7 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 |
0.1 |
GO:0002362 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment(GO:0002362) |
| 0.1 |
0.4 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.1 |
0.4 |
GO:0071681 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.1 |
0.5 |
GO:0021882 |
regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
| 0.1 |
0.4 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.1 |
0.7 |
GO:2000973 |
regulation of pro-B cell differentiation(GO:2000973) |
| 0.1 |
0.7 |
GO:1900245 |
positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.1 |
0.7 |
GO:0090154 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.1 |
0.7 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
| 0.1 |
0.7 |
GO:0050757 |
thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.1 |
1.8 |
GO:2000671 |
regulation of motor neuron apoptotic process(GO:2000671) |
| 0.1 |
0.6 |
GO:0042631 |
cellular response to water deprivation(GO:0042631) |
| 0.1 |
1.5 |
GO:0040033 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 |
0.3 |
GO:0045415 |
interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
| 0.1 |
0.2 |
GO:0021558 |
trochlear nerve development(GO:0021558) |
| 0.1 |
0.6 |
GO:0071499 |
response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
| 0.1 |
0.1 |
GO:0060178 |
regulation of exocyst localization(GO:0060178) |
| 0.1 |
0.5 |
GO:1900020 |
regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.1 |
0.7 |
GO:0030910 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.1 |
0.5 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.1 |
0.3 |
GO:0038156 |
interleukin-3-mediated signaling pathway(GO:0038156) |
| 0.1 |
0.7 |
GO:0097393 |
post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) |
| 0.1 |
0.3 |
GO:0034378 |
chylomicron assembly(GO:0034378) |
| 0.1 |
0.4 |
GO:0009816 |
defense response, incompatible interaction(GO:0009814) defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
| 0.1 |
0.3 |
GO:0070563 |
negative regulation of vitamin D receptor signaling pathway(GO:0070563) negative regulation of response to alcohol(GO:1901420) |
| 0.1 |
1.9 |
GO:0051195 |
negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.1 |
0.3 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 0.1 |
0.4 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
| 0.1 |
0.2 |
GO:0043974 |
histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 0.1 |
0.4 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.1 |
0.6 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 |
0.3 |
GO:0010536 |
positive regulation of activation of Janus kinase activity(GO:0010536) |
| 0.1 |
0.4 |
GO:1905167 |
positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.1 |
0.3 |
GO:0021682 |
nerve maturation(GO:0021682) |
| 0.1 |
0.3 |
GO:0032240 |
negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.1 |
0.3 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.1 |
0.9 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.1 |
0.5 |
GO:0050651 |
dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.1 |
0.3 |
GO:1904020 |
regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.1 |
0.3 |
GO:0098976 |
excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.1 |
1.1 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.1 |
0.5 |
GO:1902668 |
negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
| 0.1 |
1.9 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.1 |
0.5 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.1 |
0.5 |
GO:0060596 |
mammary placode formation(GO:0060596) |
| 0.1 |
2.1 |
GO:0021707 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.1 |
0.5 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 0.1 |
0.3 |
GO:0021524 |
visceral motor neuron differentiation(GO:0021524) |
| 0.1 |
2.1 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.1 |
0.3 |
GO:0061723 |
glycophagy(GO:0061723) |
| 0.1 |
0.6 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.1 |
0.4 |
GO:0036060 |
filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 0.1 |
0.2 |
GO:0001957 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 |
0.6 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.1 |
0.8 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.1 |
1.0 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.1 |
0.1 |
GO:2001027 |
negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 0.1 |
0.6 |
GO:1990166 |
protein localization to site of double-strand break(GO:1990166) |
| 0.1 |
0.3 |
GO:1904550 |
chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 0.1 |
1.2 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.1 |
0.3 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.1 |
0.5 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.1 |
0.8 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 0.1 |
0.4 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.1 |
0.5 |
GO:0007403 |
glial cell fate determination(GO:0007403) |
| 0.1 |
0.5 |
GO:0048382 |
mesendoderm development(GO:0048382) |
| 0.1 |
0.2 |
GO:0071579 |
regulation of zinc ion transport(GO:0071579) |
| 0.1 |
1.0 |
GO:0072017 |
distal tubule development(GO:0072017) |
| 0.1 |
0.4 |
GO:1905077 |
negative regulation of interleukin-17 secretion(GO:1905077) |
| 0.1 |
1.4 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.1 |
0.5 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 0.1 |
0.5 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.1 |
0.4 |
GO:1902530 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.1 |
0.1 |
GO:0071317 |
cellular response to isoquinoline alkaloid(GO:0071317) |
| 0.1 |
1.0 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.1 |
1.3 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.1 |
0.4 |
GO:0043970 |
histone H3-K9 acetylation(GO:0043970) |
| 0.1 |
0.3 |
GO:0010979 |
regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) bile acid signaling pathway(GO:0038183) |
| 0.1 |
0.3 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 0.1 |
0.3 |
GO:1902081 |
regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 0.1 |
1.2 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.1 |
0.6 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.1 |
1.2 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.1 |
1.3 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.1 |
0.2 |
GO:1904637 |
response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.1 |
0.3 |
GO:1902746 |
regulation of lens fiber cell differentiation(GO:1902746) |
| 0.1 |
2.0 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.1 |
0.3 |
GO:2000588 |
positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 0.1 |
0.3 |
GO:0030824 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 0.1 |
0.8 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.1 |
0.5 |
GO:0010996 |
response to auditory stimulus(GO:0010996) |
| 0.1 |
0.7 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.1 |
0.3 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) |
| 0.1 |
0.2 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.1 |
0.7 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
| 0.1 |
0.2 |
GO:1990051 |
activation of protein kinase C activity(GO:1990051) |
| 0.1 |
0.6 |
GO:0044334 |
canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) |
| 0.1 |
0.2 |
GO:1901642 |
purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
| 0.1 |
0.1 |
GO:0030908 |
intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 0.1 |
0.5 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.1 |
1.7 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.1 |
0.3 |
GO:2000984 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.1 |
0.7 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 0.1 |
0.7 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.1 |
0.3 |
GO:0035801 |
adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) |
| 0.1 |
0.3 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.1 |
0.6 |
GO:2001184 |
positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.1 |
1.6 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.1 |
0.8 |
GO:0060235 |
lens induction in camera-type eye(GO:0060235) |
| 0.1 |
0.2 |
GO:0072190 |
ureter urothelium development(GO:0072190) ureter morphogenesis(GO:0072197) |
| 0.1 |
0.1 |
GO:1904746 |
negative regulation of apoptotic process involved in development(GO:1904746) |
| 0.1 |
0.4 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.1 |
1.3 |
GO:1902430 |
negative regulation of beta-amyloid formation(GO:1902430) |
| 0.1 |
1.2 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.1 |
0.5 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.1 |
0.2 |
GO:1990751 |
regulation of Schwann cell chemotaxis(GO:1904266) positive regulation of Schwann cell chemotaxis(GO:1904268) Schwann cell chemotaxis(GO:1990751) |
| 0.1 |
1.7 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.1 |
0.2 |
GO:1990859 |
cellular response to endothelin(GO:1990859) |
| 0.1 |
0.2 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.1 |
3.8 |
GO:0060612 |
adipose tissue development(GO:0060612) |
| 0.1 |
0.3 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.1 |
0.2 |
GO:0045660 |
positive regulation of neutrophil differentiation(GO:0045660) |
| 0.1 |
0.2 |
GO:0061156 |
pulmonary artery morphogenesis(GO:0061156) |
| 0.1 |
0.2 |
GO:0003164 |
His-Purkinje system development(GO:0003164) Purkinje myocyte development(GO:0003165) |
| 0.1 |
0.1 |
GO:0046619 |
optic placode formation(GO:0001743) optic placode formation involved in camera-type eye formation(GO:0046619) |
| 0.1 |
0.2 |
GO:0043323 |
positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.1 |
0.5 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.1 |
0.7 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 |
0.5 |
GO:0071630 |
nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.1 |
0.5 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.1 |
0.3 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.1 |
0.3 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.1 |
1.7 |
GO:1905144 |
acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.1 |
0.2 |
GO:1904828 |
regulation of hydrogen sulfide biosynthetic process(GO:1904826) positive regulation of hydrogen sulfide biosynthetic process(GO:1904828) |
| 0.1 |
0.1 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 0.1 |
2.0 |
GO:0061157 |
mRNA destabilization(GO:0061157) |
| 0.1 |
0.3 |
GO:0090472 |
dibasic protein processing(GO:0090472) |
| 0.1 |
0.2 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.1 |
0.9 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.1 |
0.3 |
GO:0001992 |
regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.1 |
0.3 |
GO:1905071 |
occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
| 0.1 |
0.4 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.1 |
0.2 |
GO:0099526 |
presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 0.1 |
0.1 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.1 |
0.2 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 0.1 |
0.3 |
GO:0070365 |
hepatoblast differentiation(GO:0061017) hepatocyte differentiation(GO:0070365) |
| 0.1 |
0.4 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 |
0.1 |
GO:0072033 |
renal vesicle formation(GO:0072033) |
| 0.1 |
0.3 |
GO:0032329 |
serine transport(GO:0032329) |
| 0.1 |
1.3 |
GO:0051382 |
kinetochore assembly(GO:0051382) |
| 0.1 |
0.6 |
GO:0045048 |
protein insertion into ER membrane(GO:0045048) |
| 0.1 |
0.1 |
GO:0034392 |
negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
| 0.1 |
0.6 |
GO:0021840 |
directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.1 |
0.2 |
GO:2001107 |
negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
| 0.1 |
0.3 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.1 |
0.7 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.1 |
0.2 |
GO:0023016 |
signal transduction by trans-phosphorylation(GO:0023016) |
| 0.1 |
0.1 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.1 |
1.0 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.1 |
0.3 |
GO:0035283 |
central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.1 |
0.6 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.1 |
0.5 |
GO:0042795 |
snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.1 |
0.9 |
GO:0048368 |
lateral mesoderm development(GO:0048368) |
| 0.1 |
2.1 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 |
0.2 |
GO:0048687 |
positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
| 0.1 |
0.8 |
GO:0046512 |
sphingosine biosynthetic process(GO:0046512) |
| 0.1 |
0.1 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.1 |
0.1 |
GO:0090191 |
negative regulation of monocyte chemotaxis(GO:0090027) negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 0.1 |
0.2 |
GO:0048341 |
paraxial mesoderm formation(GO:0048341) |
| 0.1 |
0.1 |
GO:0043585 |
nose morphogenesis(GO:0043585) |
| 0.1 |
0.8 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.1 |
0.4 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.1 |
0.1 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.1 |
1.6 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 |
0.1 |
GO:0100012 |
regulation of heart induction by regulation of canonical Wnt signaling pathway(GO:0090081) regulation of heart induction by canonical Wnt signaling pathway(GO:0100012) |
| 0.1 |
0.2 |
GO:0072186 |
lactic acid secretion(GO:0046722) metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.1 |
0.2 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.1 |
0.2 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.1 |
0.3 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.1 |
0.4 |
GO:1904017 |
response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.1 |
0.2 |
GO:0045212 |
neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.1 |
0.9 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.1 |
0.1 |
GO:1902669 |
positive regulation of axon guidance(GO:1902669) |
| 0.1 |
0.2 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.1 |
0.3 |
GO:1901529 |
positive regulation of anion channel activity(GO:1901529) |
| 0.1 |
0.2 |
GO:0046016 |
carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite activation of transcription(GO:0045991) positive regulation of transcription by glucose(GO:0046016) |
| 0.1 |
2.2 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 |
0.6 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 |
0.2 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.1 |
1.2 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.1 |
0.2 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.1 |
2.5 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 |
0.2 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.1 |
0.4 |
GO:0051138 |
positive regulation of NK T cell differentiation(GO:0051138) |
| 0.1 |
0.1 |
GO:0070428 |
nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
| 0.1 |
0.2 |
GO:0032430 |
positive regulation of phospholipase A2 activity(GO:0032430) |
| 0.1 |
0.1 |
GO:0055005 |
ventricular cardiac myofibril assembly(GO:0055005) |
| 0.1 |
0.4 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.1 |
0.1 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.1 |
0.4 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.1 |
0.1 |
GO:0052151 |
positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.1 |
0.3 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.1 |
0.7 |
GO:1904778 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.0 |
0.1 |
GO:0061218 |
negative regulation of mesonephros development(GO:0061218) |
| 0.0 |
0.3 |
GO:2000622 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.0 |
0.1 |
GO:2001137 |
positive regulation of endocytic recycling(GO:2001137) |
| 0.0 |
0.1 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.0 |
0.2 |
GO:1902962 |
regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 0.0 |
0.1 |
GO:0072144 |
mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
| 0.0 |
0.1 |
GO:0060268 |
negative regulation of respiratory burst(GO:0060268) |
| 0.0 |
0.2 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 0.0 |
0.2 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.0 |
0.3 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.0 |
0.4 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 0.0 |
0.4 |
GO:1901836 |
regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
| 0.0 |
0.3 |
GO:0060373 |
regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.0 |
0.4 |
GO:0071313 |
cellular response to caffeine(GO:0071313) |
| 0.0 |
0.0 |
GO:0090365 |
regulation of mRNA modification(GO:0090365) negative regulation of mRNA modification(GO:0090367) |
| 0.0 |
0.2 |
GO:0042539 |
hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.0 |
0.2 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.0 |
0.2 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.0 |
0.2 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.0 |
0.1 |
GO:0003104 |
positive regulation of glomerular filtration(GO:0003104) fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.0 |
0.9 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.0 |
0.8 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 0.0 |
0.8 |
GO:0010972 |
negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.0 |
0.5 |
GO:1901250 |
regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 0.0 |
0.3 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.0 |
0.1 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.0 |
0.4 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.0 |
0.3 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.0 |
0.4 |
GO:2000980 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.0 |
0.4 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.0 |
0.1 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.0 |
0.2 |
GO:0042488 |
positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) |
| 0.0 |
0.2 |
GO:0061014 |
positive regulation of mRNA catabolic process(GO:0061014) |
| 0.0 |
0.1 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.0 |
1.7 |
GO:0000288 |
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
| 0.0 |
0.3 |
GO:0032423 |
regulation of mismatch repair(GO:0032423) |
| 0.0 |
0.3 |
GO:0060391 |
positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.0 |
0.4 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.0 |
0.3 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) |
| 0.0 |
0.5 |
GO:0033133 |
positive regulation of glucokinase activity(GO:0033133) |
| 0.0 |
0.1 |
GO:2000503 |
positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.0 |
0.5 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.0 |
0.1 |
GO:0008065 |
establishment of blood-nerve barrier(GO:0008065) positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.0 |
0.2 |
GO:0097026 |
dendritic cell dendrite assembly(GO:0097026) |
| 0.0 |
0.2 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 0.0 |
0.3 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.0 |
0.7 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 |
0.3 |
GO:0071493 |
cellular response to UV-B(GO:0071493) |
| 0.0 |
0.2 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.0 |
0.1 |
GO:0072014 |
proximal tubule development(GO:0072014) |
| 0.0 |
0.2 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.0 |
0.3 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.0 |
0.2 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.0 |
0.2 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.0 |
2.6 |
GO:0048286 |
lung alveolus development(GO:0048286) |
| 0.0 |
0.2 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.0 |
0.1 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.0 |
0.3 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 0.0 |
0.4 |
GO:0098596 |
vocal learning(GO:0042297) imitative learning(GO:0098596) |
| 0.0 |
0.8 |
GO:0043306 |
positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.0 |
0.1 |
GO:2000328 |
regulation of T-helper 17 cell lineage commitment(GO:2000328) |
| 0.0 |
0.1 |
GO:0032066 |
nucleolus to nucleoplasm transport(GO:0032066) |
| 0.0 |
0.7 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 |
0.1 |
GO:0015920 |
regulation of phosphatidylcholine catabolic process(GO:0010899) lipopolysaccharide transport(GO:0015920) |
| 0.0 |
0.1 |
GO:0015891 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.0 |
0.1 |
GO:0007191 |
adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.0 |
0.5 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.0 |
0.1 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.0 |
0.1 |
GO:0048627 |
myoblast development(GO:0048627) |
| 0.0 |
0.2 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.0 |
0.1 |
GO:2000016 |
negative regulation of determination of dorsal identity(GO:2000016) |
| 0.0 |
0.1 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.0 |
0.1 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.0 |
0.1 |
GO:1905204 |
lung lobe formation(GO:0060464) diaphragm morphogenesis(GO:0060540) negative regulation of connective tissue replacement(GO:1905204) |
| 0.0 |
0.1 |
GO:1901203 |
positive regulation of extracellular matrix assembly(GO:1901203) |
| 0.0 |
0.3 |
GO:2000394 |
positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.0 |
0.4 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.0 |
0.2 |
GO:0086098 |
angiotensin-activated signaling pathway involved in heart process(GO:0086098) negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 0.0 |
0.1 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.0 |
0.1 |
GO:0070429 |
regulation of granuloma formation(GO:0002631) negative regulation of granuloma formation(GO:0002632) regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) |
| 0.0 |
0.3 |
GO:0015820 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.0 |
0.1 |
GO:0010705 |
meiotic DNA double-strand break processing involved in reciprocal meiotic recombination(GO:0010705) |
| 0.0 |
0.7 |
GO:0042119 |
neutrophil activation(GO:0042119) |
| 0.0 |
0.1 |
GO:0019046 |
viral latency(GO:0019042) release from viral latency(GO:0019046) |
| 0.0 |
0.1 |
GO:0036509 |
trimming of terminal mannose on B branch(GO:0036509) |
| 0.0 |
0.0 |
GO:2000015 |
regulation of determination of dorsal identity(GO:2000015) |
| 0.0 |
0.1 |
GO:0001762 |
beta-alanine transport(GO:0001762) taurine transport(GO:0015734) |
| 0.0 |
0.2 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.0 |
0.2 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.0 |
0.4 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.0 |
0.1 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.0 |
0.2 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.0 |
0.2 |
GO:0090306 |
spindle assembly involved in meiosis(GO:0090306) |
| 0.0 |
0.0 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.0 |
0.3 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.0 |
0.1 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) |
| 0.0 |
0.4 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.0 |
0.1 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.0 |
0.1 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.0 |
0.5 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.0 |
0.3 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.0 |
0.4 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 |
0.0 |
GO:0002930 |
trabecular meshwork development(GO:0002930) |
| 0.0 |
0.1 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.0 |
0.0 |
GO:0072104 |
glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.0 |
0.2 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.0 |
0.2 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.0 |
0.2 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.0 |
0.6 |
GO:0021859 |
pyramidal neuron differentiation(GO:0021859) |
| 0.0 |
0.4 |
GO:0010572 |
positive regulation of platelet activation(GO:0010572) |
| 0.0 |
0.4 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
| 0.0 |
0.1 |
GO:0021559 |
trigeminal nerve development(GO:0021559) |
| 0.0 |
0.5 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.0 |
0.5 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 0.0 |
0.3 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.0 |
0.2 |
GO:0014049 |
positive regulation of glutamate secretion(GO:0014049) |
| 0.0 |
0.9 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
1.2 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.0 |
0.1 |
GO:1904948 |
midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.0 |
0.3 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.0 |
0.3 |
GO:0035745 |
T-helper 2 cell cytokine production(GO:0035745) |
| 0.0 |
0.9 |
GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
| 0.0 |
0.6 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.0 |
1.1 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.0 |
0.1 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) |
| 0.0 |
0.4 |
GO:0072673 |
lamellipodium morphogenesis(GO:0072673) |
| 0.0 |
0.6 |
GO:0036010 |
protein localization to endosome(GO:0036010) |
| 0.0 |
0.1 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.0 |
0.1 |
GO:0070494 |
regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 0.0 |
0.0 |
GO:0032906 |
transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
| 0.0 |
0.1 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.0 |
0.3 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.0 |
0.3 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.0 |
0.2 |
GO:0048505 |
regulation of timing of cell differentiation(GO:0048505) |
| 0.0 |
0.1 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.0 |
0.1 |
GO:1902866 |
regulation of retina development in camera-type eye(GO:1902866) |
| 0.0 |
0.0 |
GO:0060982 |
coronary artery morphogenesis(GO:0060982) |
| 0.0 |
0.1 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.0 |
0.2 |
GO:1901341 |
positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.0 |
0.6 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 |
0.4 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.0 |
0.8 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.0 |
0.1 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.0 |
1.9 |
GO:0045921 |
positive regulation of exocytosis(GO:0045921) |
| 0.0 |
0.5 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.0 |
0.1 |
GO:0006670 |
diacylglycerol biosynthetic process(GO:0006651) sphingosine metabolic process(GO:0006670) |
| 0.0 |
0.1 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.0 |
0.3 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.0 |
0.2 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.0 |
1.4 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.0 |
0.6 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.0 |
0.1 |
GO:0034164 |
negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.0 |
0.1 |
GO:0034311 |
diol metabolic process(GO:0034311) |
| 0.0 |
0.1 |
GO:0099566 |
regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.0 |
0.1 |
GO:0046356 |
acetyl-CoA catabolic process(GO:0046356) |
| 0.0 |
0.3 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.0 |
0.1 |
GO:0070562 |
regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.0 |
3.3 |
GO:0043149 |
contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
| 0.0 |
0.7 |
GO:0035065 |
regulation of histone acetylation(GO:0035065) |
| 0.0 |
0.1 |
GO:0021564 |
vagus nerve development(GO:0021564) |
| 0.0 |
0.4 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.0 |
0.1 |
GO:1905150 |
regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.0 |
0.3 |
GO:0014051 |
gamma-aminobutyric acid secretion(GO:0014051) |
| 0.0 |
0.1 |
GO:0002087 |
regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
| 0.0 |
1.2 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.0 |
0.1 |
GO:0038016 |
insulin receptor internalization(GO:0038016) |
| 0.0 |
0.5 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 |
0.1 |
GO:0002268 |
follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.0 |
0.4 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.0 |
0.1 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.0 |
0.1 |
GO:1903527 |
positive regulation of membrane tubulation(GO:1903527) |
| 0.0 |
0.5 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.0 |
0.2 |
GO:0097688 |
AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.0 |
0.1 |
GO:0035814 |
negative regulation of renal sodium excretion(GO:0035814) |
| 0.0 |
0.1 |
GO:0090235 |
regulation of metaphase plate congression(GO:0090235) |
| 0.0 |
0.2 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.0 |
0.1 |
GO:1902045 |
regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
| 0.0 |
1.3 |
GO:0045669 |
positive regulation of osteoblast differentiation(GO:0045669) |
| 0.0 |
0.2 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.0 |
0.4 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.0 |
0.2 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.0 |
0.1 |
GO:0061091 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.0 |
0.1 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.0 |
0.5 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.0 |
0.2 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.0 |
0.0 |
GO:0060789 |
hair follicle placode formation(GO:0060789) |
| 0.0 |
0.1 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.0 |
0.2 |
GO:1902170 |
cellular response to reactive nitrogen species(GO:1902170) |
| 0.0 |
0.3 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.0 |
0.0 |
GO:0060355 |
positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.0 |
3.6 |
GO:0035023 |
regulation of Rho protein signal transduction(GO:0035023) |
| 0.0 |
0.0 |
GO:1904378 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.0 |
0.4 |
GO:0051703 |
social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.0 |
0.0 |
GO:0090149 |
mitochondrial membrane fission(GO:0090149) |
| 0.0 |
0.3 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.0 |
0.1 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.0 |
0.1 |
GO:0042339 |
keratan sulfate metabolic process(GO:0042339) |
| 0.0 |
0.1 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.0 |
0.2 |
GO:0015722 |
canalicular bile acid transport(GO:0015722) |
| 0.0 |
0.3 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 |
0.1 |
GO:0045799 |
positive regulation of chromatin assembly or disassembly(GO:0045799) |
| 0.0 |
0.2 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.0 |
0.1 |
GO:0035660 |
MyD88-dependent toll-like receptor 4 signaling pathway(GO:0035660) |
| 0.0 |
0.6 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 |
0.1 |
GO:0033577 |
protein glycosylation in endoplasmic reticulum(GO:0033577) |
| 0.0 |
0.1 |
GO:0051792 |
medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.0 |
0.2 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.0 |
0.6 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 |
0.0 |
GO:1901509 |
regulation of endothelial tube morphogenesis(GO:1901509) |
| 0.0 |
0.1 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.0 |
0.0 |
GO:1903525 |
regulation of membrane tubulation(GO:1903525) |
| 0.0 |
0.1 |
GO:0014842 |
regulation of skeletal muscle satellite cell proliferation(GO:0014842) regulation of skeletal muscle cell proliferation(GO:0014857) |
| 0.0 |
0.6 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.0 |
0.1 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.0 |
0.2 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.0 |
0.0 |
GO:0036245 |
cellular response to menadione(GO:0036245) |
| 0.0 |
0.0 |
GO:0061056 |
sclerotome development(GO:0061056) |
| 0.0 |
0.8 |
GO:0007492 |
endoderm development(GO:0007492) |
| 0.0 |
0.1 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.0 |
0.0 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.0 |
0.0 |
GO:0035989 |
tendon development(GO:0035989) tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.0 |
0.6 |
GO:0071300 |
cellular response to retinoic acid(GO:0071300) |
| 0.0 |
0.2 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.0 |
0.1 |
GO:1901660 |
calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
| 0.0 |
0.1 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.0 |
0.1 |
GO:2000291 |
regulation of myoblast proliferation(GO:2000291) |
| 0.0 |
0.9 |
GO:0030835 |
negative regulation of actin filament depolymerization(GO:0030835) |
| 0.0 |
0.3 |
GO:0009437 |
carnitine metabolic process(GO:0009437) |
| 0.0 |
0.7 |
GO:0009880 |
embryonic pattern specification(GO:0009880) |
| 0.0 |
0.1 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 0.0 |
0.2 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.0 |
0.1 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 0.0 |
0.4 |
GO:0071526 |
semaphorin-plexin signaling pathway(GO:0071526) |
| 0.0 |
0.2 |
GO:0015816 |
glycine transport(GO:0015816) |
| 0.0 |
0.2 |
GO:0070571 |
negative regulation of neuron projection regeneration(GO:0070571) |
| 0.0 |
0.1 |
GO:0061709 |
reticulophagy(GO:0061709) |
| 0.0 |
0.0 |
GO:1903566 |
positive regulation of protein localization to cilium(GO:1903566) |
| 0.0 |
0.1 |
GO:1900113 |
negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.0 |
0.1 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.0 |
0.2 |
GO:0045823 |
positive regulation of heart contraction(GO:0045823) |
| 0.0 |
0.0 |
GO:0090004 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.0 |
0.1 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.1 |
GO:1901977 |
negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
| 0.0 |
0.1 |
GO:0038031 |
non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.0 |
0.0 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.0 |
0.2 |
GO:0048169 |
regulation of long-term neuronal synaptic plasticity(GO:0048169) |
| 0.0 |
0.1 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.0 |
0.1 |
GO:0042167 |
porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.0 |
0.1 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.0 |
0.1 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.0 |
0.0 |
GO:0021648 |
vestibulocochlear nerve morphogenesis(GO:0021648) |
| 0.0 |
0.2 |
GO:0060318 |
definitive erythrocyte differentiation(GO:0060318) |
| 0.0 |
0.3 |
GO:1990845 |
adaptive thermogenesis(GO:1990845) |
| 0.0 |
0.1 |
GO:0002634 |
regulation of germinal center formation(GO:0002634) |
| 0.0 |
0.4 |
GO:0031112 |
positive regulation of microtubule polymerization or depolymerization(GO:0031112) |
| 0.0 |
0.2 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.0 |
0.6 |
GO:0003407 |
neural retina development(GO:0003407) |
| 0.0 |
0.1 |
GO:0043562 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 |
0.1 |
GO:1903818 |
positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.0 |
0.0 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.0 |
0.2 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.0 |
0.2 |
GO:0035459 |
cargo loading into vesicle(GO:0035459) |
| 0.0 |
0.2 |
GO:0010801 |
negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.0 |
0.1 |
GO:0090267 |
positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.0 |
0.2 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.0 |
0.4 |
GO:0030199 |
collagen fibril organization(GO:0030199) |
| 0.0 |
0.0 |
GO:0072717 |
response to actinomycin D(GO:0072716) cellular response to actinomycin D(GO:0072717) |
| 0.0 |
0.2 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.0 |
0.2 |
GO:0070070 |
proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.0 |
0.2 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.0 |
0.1 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.0 |
0.0 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.0 |
0.1 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.0 |
0.1 |
GO:2000352 |
negative regulation of endothelial cell apoptotic process(GO:2000352) |
| 0.0 |
0.4 |
GO:0043407 |
negative regulation of MAP kinase activity(GO:0043407) |
| 0.0 |
0.0 |
GO:0043587 |
tongue morphogenesis(GO:0043587) |
| 0.0 |
0.2 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.0 |
0.0 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) |
| 0.0 |
0.1 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.0 |
0.0 |
GO:0060372 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 0.0 |
0.5 |
GO:0000768 |
syncytium formation by plasma membrane fusion(GO:0000768) |
| 0.0 |
0.2 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.0 |
0.1 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.0 |
0.0 |
GO:0098963 |
dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
| 0.0 |
0.1 |
GO:0017062 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
| 0.0 |
0.0 |
GO:0060857 |
establishment of glial blood-brain barrier(GO:0060857) |
